Stocks in Play: Bausch Health Companies Inc. - InvestingChannel

Stocks in Play: Bausch Health Companies Inc.

Friday, September 23, 2022

11:28 AM EST – Bausch Health Companies Inc. : And Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced that RYALTRIS® (olopatadine hydrochloride and mometasone furoate nasal spray) has been approved by Health Canada for the symptomatic treatment of moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged six years and older. Bausch Health Companies Inc. (T.BHC) shares were down $0.20 at 9.43.

Stocks in Play: Bausch Health Companies Inc., Fri, 23 Sep 2022 11:42:07 EST

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire